In cost-saving move, Medicare could limit patient access to Alzheimer’s treatment

By Cassidy Morrison

Published June 29, 2021 10:30am ET

In cost-saving move, Medicare could limit patient access to Alzheimer’s treatment — Medicare might restrict patient access to Alzheimer’s treatment priced at $56,000 for a year’s supply to soften the financial blow to the federal insurance program’s budget. “Whether or not that drug will be covered by Medicare and Medicaid is is an outstanding question, something that HHS will have to deal with,” said Health and Human […]

Medicare might restrict patient access to Alzheimer’s treatment priced at $56,000 for a year’s supply to soften the financial blow to the federal insurance program’s budget.

“Whether or not that drug will be covered by Medicare and Medicaid is is an outstanding question, something that HHS will have to deal with,” said Health and Human Services Secretary Xavier Becerra last week.